These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19601769)

  • 1. Neurodegeneration in Niemann-Pick Type C disease and Huntington's disease: impact of defects in membrane trafficking.
    Schweitzer JK; Krivda JP; D'Souza-Schorey C
    Curr Drug Targets; 2009 Jul; 10(7):653-65. PubMed ID: 19601769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological cholesterol metabolism fails to modify electrophysiological properties of afflicted neurones in Niemann-Pick disease type C.
    Deisz RA; Meske V; Treiber-Held S; Albert F; Ohm TG
    Neuroscience; 2005; 130(4):867-73. PubMed ID: 15652985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodegeneration in Niemann-Pick Type C Disease: An Updated Review on Pharmacological and Non-Pharmacological Approaches to Counteract Brain and Cognitive Impairment.
    Cariati I; Masuelli L; Bei R; Tancredi V; Frank C; D'Arcangelo G
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34202978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuronal loss of Drosophila NPC1a causes cholesterol aggregation and age-progressive neurodegeneration.
    Phillips SE; Woodruff EA; Liang P; Patten M; Broadie K
    J Neurosci; 2008 Jun; 28(26):6569-82. PubMed ID: 18579730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration in Niemann-Pick type C disease mice.
    Ong WY; Kumar U; Switzer RC; Sidhu A; Suresh G; Hu CY; Patel SC
    Exp Brain Res; 2001 Nov; 141(2):218-31. PubMed ID: 11713633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues to neuro-degeneration in Niemann-Pick type C disease from global gene expression profiling.
    Reddy JV; Ganley IG; Pfeffer SR
    PLoS One; 2006 Dec; 1(1):e19. PubMed ID: 17183645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular mechanism of U18666A-mediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease.
    Koh CH; Cheung NS
    Cell Signal; 2006 Nov; 18(11):1844-53. PubMed ID: 16797161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol in Niemann-Pick Type C disease.
    Bi X; Liao G
    Subcell Biochem; 2010; 51():319-35. PubMed ID: 20213549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular accumulation of amyloidogenic fragments of amyloid-beta precursor protein in neurons with Niemann-Pick type C defects is associated with endosomal abnormalities.
    Jin LW; Shie FS; Maezawa I; Vincent I; Bird T
    Am J Pathol; 2004 Mar; 164(3):975-85. PubMed ID: 14982851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imatinib therapy blocks cerebellar apoptosis and improves neurological symptoms in a mouse model of Niemann-Pick type C disease.
    Alvarez AR; Klein A; Castro J; Cancino GI; Amigo J; Mosqueira M; Vargas LM; Yévenes LF; Bronfman FC; Zanlungo S
    FASEB J; 2008 Oct; 22(10):3617-27. PubMed ID: 18591368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niemann-Pick Disease Type C: from molecule to clinic.
    Tang Y; Li H; Liu JP
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):132-40. PubMed ID: 19566836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The autophagic defect in Niemann-Pick disease type C neurons differs from somatic cells and reduces neuronal viability.
    Meske V; Erz J; Priesnitz T; Ohm TG
    Neurobiol Dis; 2014 Apr; 64():88-97. PubMed ID: 24412309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic dissection of a cell-autonomous neurodegenerative disorder: lessons learned from mouse models of Niemann-Pick disease type C.
    Lopez ME; Scott MP
    Dis Model Mech; 2013 Sep; 6(5):1089-100. PubMed ID: 23907005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of Pathologic Lipid Accumulation in NPC1-Deficient Neurons by Drug-Promoted Release of LAMP1-Coated Lamellar Inclusions.
    Demais V; Barthélémy A; Perraut M; Ungerer N; Keime C; Reibel S; Pfrieger FW
    J Neurosci; 2016 Jul; 36(30):8012-25. PubMed ID: 27466344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol involvement in the pathogenesis of neurodegenerative diseases.
    Liu JP; Tang Y; Zhou S; Toh BH; McLean C; Li H
    Mol Cell Neurosci; 2010 Jan; 43(1):33-42. PubMed ID: 19660552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments.
    Akbergenova Y; Littleton JT
    J Neurosci; 2017 Mar; 37(12):3425-3439. PubMed ID: 28235896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous and synthetic neurosteroids in treatment of Niemann-Pick Type C disease.
    Mellon SH; Gong W; Schonemann MD
    Brain Res Rev; 2008 Mar; 57(2):410-20. PubMed ID: 17629950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Niemann-Pick type C disease: a fat problem.
    Vincent I; Bu B; Erickson RP
    Curr Opin Neurol; 2003 Apr; 16(2):155-61. PubMed ID: 12644742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.